BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Urgent Field Safety Notice for BIOCREDIT COVID-19 Ag by Rapigen Inc.

Product group In-vitro diagnostics - microbiological products
Reference 07756/22

For further information as well as details concerning the device please see the enclosed Advisory Notice of the manufacturer.

Urgent Field Safety Notice for BIOCREDIT COVID-19 Ag by Rapigen Inc. , Download_VeroeffentlichtAm_EN PDF, 119KB, File does not meet accessibility standards